Aspen Pharmacare Nigeria Ltd was incorporated on 4th September 2012. It is a subsidiary of Aspen Group, SA which has a proud heritage of more than 160 years’ operating in more than 150 countries across the world .
Aspen Pharmacare Nigeria has its footprints in Nigeria, and its distribution covers all the 6 Geo political Zones of Nigeria.
The African continent offers a promising window of opportunity for pharmaceutical expansion. South African-based Aspen Pharmacare, which has manufacturing facilities valued in excess of R1 billion and which produce approximately 6 billion tablets per annum, is suitably positioned to manufacture and supply product across Africa.
With its South African presence established, Aspen has been actively engaged in securing strategic alliances with international partners, including those based in Africa, in a bid to increase its geographic footprint in this territory.
Aspen’s position in Africa through its relationships with international pharmaceutical companies Gilead Sciences Inc and Tibotec Pharmaceuticals Limited, has positioned the company at the forefront of introducing first world technology to the continent to support the implementation of the latest guidelines and protocols for the treatment of HIV/Aids.
Aspen’s range of anti-retrovirals, which include treatment products such as Viread, Truvada and Presista, has established the Group as a valued contributor in the fight against HIV/Aids on the continent.
Aspen’s strategic approach toward providing meaningful solutions against infectious diseases, as well as securing appropriate international partnerships, has created an opportunity for the Group to create a pharmaceutical legacy across the African continent.
Vision and Mission
To deliver value to all our stakeholders as a responsible corporate Citizen that provides quality, affordable medicines & products globally.